Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.48 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14404929 | 1.00 | LMNA (0.51) | LMNARNPEPFOLH1MAPK1ALDH1A1 | |
| SCHEMBL3869337 | 1.00 | LMNA (0.51) | LMNARNPEPFOLH1MAPK1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL11125960 | 0.98 | LMNA (0.50) | LMNARNPEPFOLH1MAPK1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL28941784 | 0.98 | LMNA (0.50) | LMNARNPEPFOLH1MAPK1ALDH1A1 | |
| Acrylic Acid SCHEMBL1536190 | 0.90 | LMNA (0.44) | LMNARNPEPFOLH1MAPK1ALDH1A1 | |
| SCHEMBL2118366 | 0.85 | RNPEP (0.46) | LMNARNPEPFOLH1MAPK1ALDH1A1 | |
| SCHEMBL2118362 | 0.85 | RNPEP (0.46) | LMNARNPEPFOLH1MAPK1ALDH1A1 | |
| SCHEMBL10296118 | 0.85 | LMNA (0.42) | LMNARNPEPFOLH1MAPK1ALDH1A1 | |
| SCHEMBL5179354 | 0.84 | RNPEP (0.48) | LMNARNPEPFOLH1MAPK1ALDH1A1 | |
| SCHEMBL149342 | 0.84 | RNPEP (0.48) | LMNARNPEPFOLH1MAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117320685-A | Composition for skin protection comprising an antimicrobial agent and a (bio) -alkanediol | 西姆莱斯股份公司 | 2023-12-29 | — | — | CN | disclosed |
| CN-116685300-A | Composition comprising one or more (bio) -alkanediols with an antioxidant | 西姆莱斯股份公司 | 2023-09-01 | — | — | CN | disclosed |
| CN-116234802-A | Quinoline CGAS antagonist compounds | 免疫传感器治疗股份有限公司 | 2023-06-06 | — | — | CN | disclosed |
| CN-109929820-B | Novel glycerol mono-diacyl ester lipase | 丰益(上海)生物技术研发中心有限公司 | 2022-10-11 | — | — | CN | disclosed |
| CN-114836400-A | Enzyme participating in synthesis of bacteriophage diaminopurine and application thereof | 天津大学 | 2022-08-02 | — | — | CN | disclosed |
| CN-114836399-A | Preparation method of isoguanine deoxyribonucleotide | 天津大学 | 2022-08-02 | — | — | CN | disclosed |
| CN-113186181-A | Xanthine amide hydrolase and use thereof | 天津大学 | 2021-07-30 | — | — | CN | disclosed |
| CN-113186180-A | 4-ureido-5-carboxyl imidazole amide hydrolase and application thereof | 天津大学 | 2021-07-30 | — | — | CN | disclosed |
| CN-113122520-A | Novel glycerol mono-diacyl ester lipase | 丰益(上海)生物技术研发中心有限公司 | 2021-07-16 | — | — | CN | disclosed |
| CN-113025595-A | Acid-tolerant lipases | 丰益(上海)生物技术研发中心有限公司 | 2021-06-25 | — | — | CN | disclosed |
| CN-103875921-A | Methods For Enhancing The Palatability Of Compositions For Consumption By Animals | HILLS PET NUTRITION INC | 2014-06-25 | — | — | CN | disclosed |
| EP-1677816-A4 | THERAPEUTIC METHOD | UNIV MONASH (AU) | 2009-04-22 | — | — | EP | disclosed |
| CN-101365492-A | Transglutaminase mediated conjugation of growth hormone | NOVO NORDISK HEALTHCARE AG (CH) | 2009-02-11 | — | — | CN | disclosed |
| CN-101128125-A | Methods for enhancing palatability of compositions for animal consumption | HILLS PET NUTRITION INC (US) | 2008-02-20 | — | — | CN | disclosed |
| EP-1677816-A1 | THERAPEUTIC METHOD | MONASH UNIVERSITY (AU) | 2006-07-12 | — | — | EP | disclosed |
| EP-1572114-A2 | GLYCOSYLCERAMIDE ANALOGUES | BIOMIRA, INC. (CA) | 2005-09-14 | — | — | EP | disclosed |
| WO-2005032578-A1 | THERAPEUTIC METHOD | MONASH UNIVERSITY (AU) | 2005-04-14 | — | — | WO | disclosed |
| WO-2004028475-A2 | GLYCOSYLCERAMIDE ANALOGUES | BIOMIRA, INC. (CA) | 2004-04-08 | — | — | WO | disclosed |
| EP-0894010-A2 | DENATURANTS FOR SYMPATHOMIMETIC AMINE SALTS | Warner-Lambert Company LLC (US) | 1999-02-03 | — | — | EP | disclosed |
| WO-1997037689-A2 | DENATURANTS FOR SYMPATHOMIMETIC AMINE SALTS | WARNER-LAMBERT COMPANY (US) | 1997-10-16 | — | — | WO | disclosed |